Effect of NFE2L2 Genetic Polymorphism on the Association Between Oral Estrogen Therapy and the Risk of Venous Thromboembolism in Postmenopausal Women

被引：21

作者：

Bouligand, J. ^{[1
,2
]}

Cabaret, O. ^{[1
]}

Canonico, M. ^{[3
,4
]}

Verstuyft, C. ^{[1
,5
]}

Dubert, L. ^{[5
]}

Becquemont, L. ^{[1
,5
]}

Guiochon-Mantel, A. ^{[1
,2
,4
]}

Scarabin, P. Y. ^{[3
]}

机构：

[1] Univ Paris Sud, Hop Bicetre, AP HP, Lab Genet Mol Pharmacogenet & Hormonol, F-94275 Le Kremlin Bicetre, France

[2] Univ Paris Sud, INSERM, U693, F-94275 Le Kremlin Bicetre, France

[3] INSERM, CESP Ctr Res Epidemiol & Populat Hlth, U1018, Villejuif, France

[4] Univ Paris Sud, UMRS 1018, Villejuif, France

[5] Univ Paris Sud, Dept Pharmacol, Fac Med Paris Sud, F-94275 Le Kremlin Bicetre, France

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2011年 / 89卷 / 01期

关键词：

ANTIOXIDANT RESPONSE ELEMENT; TRANSCRIPTION FACTOR NRF2; REPLACEMENT THERAPY; OXIDATIVE STRESS; HORMONE-THERAPY; CONSENSUS SEQUENCE; ACTIVATION; IDENTIFICATION; INFLAMMATION; EXPRESSION;

D O I：

10.1038/clpt.2010.241

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Oral, but not transdermal, estrogen therapy increases the risk of venous thromboembolism (VTE) in women who are past menopause. Data from the Estrogen and Thromboembolism Risk (ESTHER) study were used to investigate the effects of the genetic polymorphism of NFE2L2 rs6721961, which may impair Nrf2-dependent hepatic conjugation of estrogen metabolites. As compared with nonusers, the odds ratio (OR) for VTE in current users of oral estrogens was 2.5 (95% confidence interval (CI): 1.3-4.8) in patients with wildtype NFE2L2 and 17.9 (95% CI: 3.7-85.7) in those with the polymorphism (interaction, P = 0.01).

引用

页码：60 / 64

页数：5

共 30 条

[1] Cardiovascular risk factors and venous thromboembolism - A meta-analysis [J].

Ageno, Walter ;

Becattini, Cecilia ;

Brighton, Timothy ;

Selby, Rita ;

Kamphuisen, Pieter W. .

CIRCULATION, 2008, 117 (01) :93-102

[2] Repression of cancer protective genes by 17β-estradiol:: Ligand-dependent interaction between human Nrf2 and estrogen receptor α [J].

Ansell, PJ ;

Lo, SC ;

Newton, LG ;

Espinosa-Nicholas, C ;

Zhang, DD ;

Liu, JH ;

Hannink, M ;

Lubahn, DB .

MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2005, 243 (1-2) :27-34

[3] In vitro and in vivo regulation of antioxidant response element-dependent gene expression by estrogens [J].

Ansell, PJ ;

Espinosa-Nicholas, C ;

Curran, EM ;

Judy, BM ;

Philips, BJ ;

Hannink, M ;

Lubahn, DB .

ENDOCRINOLOGY, 2004, 145 (01) :311-317

[4]

CAINE YG, 1992, THROMB HAEMOSTASIS, V68, P392

[5] Synergism between oral estrogen therapy and cytochrome P450 3A5*1 allele on the risk of venous thromboembolism among postmenopausal women [J].

Canonico, Marianne ;

Bouaziz, Elodie ;

Carcaillon, Laure ;

Verstuyft, Celine ;

Guiochon-Mantel, Anne ;

Becquemont, Laurent ;

Scarabin, Pierre-Yves .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (08) :3082-3087

[6] Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis [J].

Canonico, Marianne ;

Plu-Bureau, Genevieve ;

Lowe, Gordon D. O. ;

Scarabin, Pierre-Yves .

BMJ-BRITISH MEDICAL JOURNAL, 2008, 336 (7655) :1227-+

[7] Hormone therapy and venous thromboembolism among postmenopausal women -: Impact of the route of estrogen administration and progestogens:: The ESTHER study [J].

Canonico, Marianne ;

Oger, Emmanuel ;

Plu-Bureau, Genevieve ;

Conard, Jacqueline ;

Meyer, Guy ;

Levesque, Herve ;

Trillot, Nathalie ;

Barrellier, Marie-Therese ;

Wahl, Denis ;

Emmerich, Joseph ;

Scarabin, Pierre-Yves .

CIRCULATION, 2007, 115 (07) :840-845

[8] Postmenopausal Hormone Therapy and Risk of Idiopathic Venous Thromboembolism Results From the E3N Cohort Study [J].

Canonico, Marianne ;

Fournier, Agnes ;

Carcaillon, Laure ;

Olie, Valerie ;

Plu-Bureau, Genevieve ;

Oger, Emmanuel ;

Mesrine, Sylvie ;

Boutron-Ruault, Marie-Christine ;

Clavel-Chapelon, Francoise ;

Scarabin, Pierre-Yves .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (02) :340-345

[9] An important function of Nrf2 in combating oxidative stress: Detoxification of acetaminophen [J].

Chan, KM ;

Han, XD ;

Kan, YW .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (08) :4611-4616

[10] Gene expression profiling of NRF2-mediated protection against oxidative injury [J].

Cho, HY ;

Reddy, SP ;

DeBiase, A ;

Yamamoto, M ;

Kleeberger, SR .

FREE RADICAL BIOLOGY AND MEDICINE, 2005, 38 (03) :325-343

← 1 2 3 →